{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:39:15Z","timestamp":1787837955107,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008556","name":"Paul MacKall and Evanina Bell MacKall Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.exer.2009.10.001","type":"journal-article","created":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T04:13:00Z","timestamp":1256789580000},"page":"146-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species"],"prefix":"10.1016","volume":"90","author":[{"given":"Zhao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Wai","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel Y.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Peterson-Yantorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Guo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhalchandra","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Besada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lak Shin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortimer M.","family":"Civan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2009.10.001_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0002-9394(73)91015-5","article-title":"Ocular penetration of pilocarpine in primates","volume":"75","author":"Asseff","year":"1973","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2009.10.001_bib2","first-page":"1841","article-title":"Reliable measurement of mouse intraocular pressure by a servo-null micropipette system","volume":"42","author":"Avila","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.10.001_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bjp.0704267","article-title":"A(1)-, A(2A)- and A(3)-subtype adenosine receptors modulate intraocular pressure in the mouse","volume":"134","author":"Avila","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2009.10.001_bib4","first-page":"1897","article-title":"Inhibitors of NHE-1 Na+\/H+ exchange reduce mouse intraocular pressure","volume":"43","author":"Avila","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.10.001_bib6","first-page":"3021","article-title":"Knockout of A(3) adenosine receptors reduces mouse intraocular pressure","volume":"43","author":"Avila","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.10.001_bib3","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1167\/iovs.04-1188","article-title":"Noninvasive intraocular pressure measurements in mice by pneumotonometry","volume":"46","author":"Avila","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.10.001_bib7","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1135\/cccc20060912","article-title":"Nucleoside prodrugs of A3 adenosine receptor agonists and antagonists","volume":"71","author":"Besada","year":"2006","journal-title":"Coll. Czech Chem. Comm."},{"key":"10.1016\/j.exer.2009.10.001_bib8","doi-asserted-by":"crossref","first-page":"C1354","DOI":"10.1152\/ajpcell.1997.273.4.C1354","article-title":"Adenosine stimulates Cl\u2212 channels of nonpigmented ciliary epithelial cells","volume":"273","author":"Carr\u00e9","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.exer.2009.10.001_bib9","doi-asserted-by":"crossref","first-page":"C440","DOI":"10.1152\/ajpcell.2000.279.2.C440","article-title":"Similarity of A(3)-adenosine and swelling-activated Cl(-) channels in nonpigmented ciliary epithelial cells","volume":"279","author":"Carr\u00e9","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2009.10.001_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2009.10.001_bib35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2009.10.001_bib13","doi-asserted-by":"crossref","first-page":"C1003","DOI":"10.1152\/ajpcell.00175.2004","article-title":"cAMP-activated maxi-Cl\u2212 channels in native bovine pigmented ciliary epithelial cells","volume":"287","author":"Do","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2009.10.001_bib11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1167\/iovs.04-1004","article-title":"Inhibition of swelling-activated Cl\u2212 currents by functional anti-ClC-3 antibody in native bovine non-pigmented ciliary epithelial cells","volume":"46","author":"Do","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.10.001_bib12","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1167\/iovs.05-0851","article-title":"Swelling-activated Cl\u2212 channels support Cl\u2212 secretion by bovine ciliary epithelium","volume":"47","author":"Do","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.10.001_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00232-002-2013-5","article-title":"Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport","volume":"193","author":"Fleischhauer","year":"2003","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.exer.2009.10.001_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0006-2952(00)00570-0","article-title":"Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells","volume":"61","author":"Fredholm","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exer.2009.10.001_bib17","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1021\/jm020211+","article-title":"Structural determinants of A3 adenosine receptor activation: nucleoside ligands at the agonist\/antagonist boundary","volume":"45","author":"Gao","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exer.2009.10.001_bib16","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.bmcl.2005.10.054","article-title":"Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety","volume":"16","author":"Gao","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.exer.2009.10.001_bib18","first-page":"137","article-title":"Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility","volume":"42","author":"Honjo","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.10.001_bib19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0028-3908(97)00104-4","article-title":"Pharmacological characterization of novel A3 adenosine receptor-selective antagonists","volume":"36","author":"Jacobson","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.exer.2009.10.001_bib20","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1021\/jm070259t","article-title":"Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists","volume":"50","author":"Jeong","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exer.2009.10.001_bib21","doi-asserted-by":"crossref","first-page":"C784","DOI":"10.1152\/ajpcell.00333.2004","article-title":"Differential P1-purinergic modulation of human Schlemm's canal inner-wall cells","volume":"288","author":"Karl","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2009.10.001_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.exer.2006.09.007","article-title":"Cell-specific differential modulation of human trabecular meshwork cells by selective adenosine receptor agonists","volume":"84","author":"Karl","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2009.10.001_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.exer.2009.10.001_bib24","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1021\/jm00047a018","article-title":"2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors","volume":"37","author":"Kim","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exer.2009.10.001_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev.pharmtox.41.1.775","article-title":"Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection","volume":"41","author":"Linden","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.exer.2009.10.001_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.exer.2009.10.001_bib28","doi-asserted-by":"crossref","first-page":"C659","DOI":"10.1152\/ajpcell.1999.276.3.C659","article-title":"A3 adenosine receptors regulate Cl\u2212 channels of nonpigmented ciliary epithelial cells","volume":"276","author":"Mitchell","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.exer.2009.10.001_bib27","doi-asserted-by":"crossref","first-page":"C315","DOI":"10.1152\/ajpcell.00544.2001","article-title":"Human trabecular meshwork cell volume regulation","volume":"283","author":"Mitchell","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2009.10.001_bib29","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1021\/jm049580r","article-title":"(N)-methanocarba 2, N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists","volume":"48","author":"Tchilibon","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exer.2009.10.001_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","author":"The AGIS investigators","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2009.10.001_bib31","article-title":"Refinements of invasive and non-invasive mouse intraocular pressure measurements (letter)","author":"Wang","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2009.10.001_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.exer.2007.03.006","article-title":"Barrier qualities of the mouse eye to topically applied drugs","volume":"85","author":"Wang","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2009.10.001_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/02713680590953147","article-title":"The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure","volume":"30","author":"Yang","year":"2005","journal-title":"Curr. Eye Res."},{"issue":"Pt 2","key":"10.1016\/j.exer.2009.10.001_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1113\/jphysiol.1997.sp021935","article-title":"Three different Cl\u2212 channels in the bovine ciliary epithelium activated by hypotonic stress","volume":"499","author":"Zhang","year":"1997","journal-title":"J. Physiol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483509002942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483509002942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:52:28Z","timestamp":1757998348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483509002942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0014483509002942"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2009.10.001","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2009.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}